Welcome to the PDIG section of the GHP website.

Our Autumn Symposium programme is now available here.

Latest posts for PDIG

PDIG Autumn Symposium– Thursday 2nd November 2017

GHP Procurement & Distribution Interest Group (PDIG)

We are delighted to open applications for our Autumn Symposium.  The details are…

Thursday 2nd November 2007,

Hilton Birmingham Metropole Hotel, National Exhibition Centre, B40 1PP


PDIG November 2017 Symposium Programme

Application Form

PDIG November 2017 Application Form

Please send all application forms and conference queries to Noeline Johnston.

E-mail address: noeline.johnston@unitetheunion.org

Tel: 028 90232381 (switchboard) or 028 90029412 (direct dial)


Summer Symposium Programme – Wednesday 21st June 2017

Programme.  More details here…PDIG June 2017

The presentations from the summer symposium are now available here…

Peter Huskinson

Jatinder Harchowal

Graeme Kirkpatrick

Tim Root

Richard Nuttal




9.00am      Arrival, Registration, Coffee & Tea
10.00am      Chairman’s Welcome & Introduction    Margaret Dolan,  Chair, PDIG  
10.10am      NHS Medicines Contracting – The Future!


§  What contracting process will be used and what will be the impact upon existing structures and systems?

§  What are the challenges and opportunities?

§  How will the NHS and Pharmaceutical Industry work in partnership?

Peter Huskinson
National Commercial Director,
Specialised Commissioning,
NHS England 


10.50am Specialist Pharmacy Services (SPS)  and the National Standardisation programme


§  What is the role of  SPS?

§  What is the plan for a Catalogue of NHS-made medicines?

§  What else is on the workplan for NHS-made medicines?

    Tim Root

     Specialist Pharmacist,

Clinical  Governance & Technical Services,

NHS Specialist Pharmacy Service



11.30am     Tea/Coffee
12.00noon Cancer Medicines – The Transformation


§  How has the funding and evaluation of cancer drugs changed?

§  How will biosimilar monoclonal antibodies be introduced into practice?

§  What are the Cancer Vanguards and how will they impact on cancer treatments?

    David Thomson

Chemotherapy Pharmacist –NHS England
Chemotherapy CRG & National Cancer Drug

   Jatinder Harchowal,
Chief Pharmacist / Clinical Director,
Medicines Management & Clinical Support
Services Business Unit, Pharmacy Dept

The Royal Marsden NHS Foundation Trust

1.00pm     Lunch
2.15pm      Restricted use of open systems for injectable
medication – background and implications
§  Background to development of patient safety alerts

§  Background to the ‘open systems’ alert

§  Implications of the alert for Pharmacy and the pharmaceutical industry

Graeme KirkpatrickHead of Patient Safety (Advice and  Guidance) NHS Improvement



2.45pm     The challenges of NHS Medicines Procurement and
Distribution? – Industry Views    
A panel discussion
§  What are the most significant current issues?

§  What plans are in place to address these?

§  How can the NHS assist?

   Dr Rick Greville

Director Wales and Director Distribution &

Supply, ABPI

   Geoff Mellor

Technical Director

Healthcare Distribution Association
   Warwick Smith

   Director General, BGMA

Wednesday 21st June 2017 at the “Hilton Birmingham Metropole Hotel”

National Exhibition Centre, Birmingham B40 1PP Tel: 0121 780 4242


    Summary and Close    Margaret Dolan, Chair, PDIG